Eisai is in agreement with ALMIRALL PRODESFARMA of Spain to manufacture and market Cinitapride in China. Earlier Eisai had a similar agreement with Almirall for Ebastine.
Ebastine and Cinitapride are the research products of Almirall which a spanish integrated Pharma company.
Saturday, June 5, 2010
Eisai china inlicenses cinitapride
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment